2020 Scheme cancelled due to COVID-19
It is with deep regret that the Life Sciences Summer School Programme has been cancelled for 2020, regrettably we will not be offering any studentships this year. Our research laboratories are effectively closed with no confirmed reopening date which presents difficulties in offering summer studentships.
If you have already applied you should now have received communication, if you have any questions please email email@example.com
We realise that this will be deeply disappointing and would encourage you, if eligible, to apply for the 2021 scheme. We wish you all well in these difficult times and thank you for your interest in our scheme.
The Wellcome Centre for Anti-Infectives Research (WCAIR) aims to tackle the urgent unmet medical need and lack of drug discovery research for Neglected Tropical Diseases (NTDs). WCAIR consolidates the existing world-leading NTD drug discovery expertise within the Drug Discovery Unit, the Mode of Action group and the Parasitology research groups providing a continuum from discovery science to pre-clinical candidate selection.
With an initial focus on visceral leishmaniasis (VL) and Chagas’ disease (CD) the Centre will deliver high-quality pre-clinical drug candidate for each disease. To achieve our research will include:
· Innovate drug discovery approaches for VL and CD, including developing in silico and animal models that have improved prediction of Pharmacokinetic/Pharmacodynamic relationships and clinical efficacy.
· Increased exploitation of novel drug targets, through structure-based drug discovery.
· Develop tool compounds with known pharmacology to enable further understanding of parasite biology.
· Improve the efficiency of drug discovery by establishing groups to facilitate compound scale up, compound purification and formatting.
For further information about WCAIR please click here.